Lymph node staging by positron emission tomography in cervical cancer: Relationship to prognosis

Journal of Clinical Oncology

Volumn 28, Issue 12, 2010, Pages 2108-2113

  Kidd, Elizabeth A ^a   Siegel, Barry A ^a   Dehdashti, Farrokh ^a   Rader, Janet S ^a   Mutch, David G ^a   Powell, Matthew A ^a   Grigsby, Perry W ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FEMALE; HUMAN; LYMPH NODE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROGNOSIS; UTERINE CERVIX CANCER; ADJUVANT CHEMOTHERAPY; ADJUVANT THERAPY; CHI SQUARE DISTRIBUTION; GYNECOLOGIC SURGERY; KAPLAN MEIER METHOD; METHODOLOGY; MORTALITY; PREDICTION AND FORECASTING; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RECURRENT DISEASE; REGISTER; RISK ASSESSMENT; SCINTISCANNING; TIME; TREATMENT OUTCOME; UTERINE CERVIX TUMOR;

DIAGNOSTIC AGENT; FLUORODEOXYGLUCOSE F 18; RADIOPHARMACEUTICAL AGENT;

CHEMOTHERAPY, ADJUVANT; CHI-SQUARE DISTRIBUTION; FEMALE; FLUORODEOXYGLUCOSE F18; GYNECOLOGIC SURGICAL PROCEDURES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODES; LYMPHATIC METASTASIS; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY; PREDICTIVE VALUE OF TESTS; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; RADIOPHARMACEUTICALS; RADIOTHERAPY, ADJUVANT; RECURRENCE; REGISTRIES; RISK ASSESSMENT; TIME FACTORS; TREATMENT OUTCOME; UTERINE CERVICAL NEOPLASMS;

EID: 77951645269     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.25.4151     Document Type: Article

References (29)

1. Delgado G, Bundy B, Zaino R, et al: Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: A Gynecologic Oncology Group study. Gynecol Oncol 38:352-357, 1990 (Pubitemid 20362555)
2. Tinga DJ, Timmer PR, Bouma J, et al: Prognostic significance of single versus multiple lymph node metastases in cervical carcinoma stage IB. Gynecol Oncol 39:175-180, 1990 (Pubitemid 20372408)
3. Stehman F, Bundy B, DiSaia PJ, et al: Carcinoma of the cervix treated with irradiation therapy: I. A multi-variate analysis of prognostic variables in the Gynecologic Oncology Group. Cancer 67:2776-2785, 1991
4. Pecorelli S, Zigliani L, Odicino F: Revised FIGO staging for carcinoma of the cervix. Int J Gynaecol Obstet 105:107-108, 2009
5. Scheidler J, Hricak H, Yu KK, et al: Radiological evaluation of lymph node metastases in patients with cervical cancer: A meta-analysis. JAMA 278: 1096-1101, 1997 (Pubitemid 27418338)
6. Rose PG, Adler LP, Rodriguez M, et al: Positron emission tomography for evaluating paraaortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study. J Clin Oncol 17:41-45, 1999 (Pubitemid 29022376)
7. Sugawara Y, Eisbruch A, Kosuda S, et al: Evaluation of FDG PET in patients with cervical cancer. J Nucl Med 40:1125-1131, 1999 (Pubitemid 29315502)
8. Grigsby PW, Siegel BA, Dehdashti F: Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. J Clin Oncol 19:3745-3749, 2001 (Pubitemid 32844787)
9. Sironi S, Buda A, Picchio M, et al: Lymph node metastasis in patients with clinical early-stage cervical cancer: Detection with integrated FDG PET/CT. Radiology 238:272-279, 2006 (Pubitemid 43010605)
10. Bellomi M, Bonomo G, Landoni F, et al: Accuracy of computed tomography and magnetic resonance imaging in the detection of lymph node involvement in cervix carcinoma. Eur Radiol 15:2469-2474, 2005 (Pubitemid 43153848)
11. Havrilesky LJ, Kulasingam SL, Matchar DB, et al: FDG-PET for management of cervical and ovarian cancer. Gynecol Oncol 97:183-191, 2005 (Pubitemid 40403692)
12. Wright JD, Dehdashti F, Herzog TJ, et al: Preoperative lymph node staging of early-stage cervical carcinoma by [18F]-fluoro-2-deoxy-D-glucose-positron emission tomography. Cancer 104:2484-2491, 2005
13. Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus of the Imaging Subcommittee of International Harmonization Project in Lymphoma. J Clin Oncol 25:571-578, 2007 (Pubitemid 350002965)
14. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
15. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-220, 1972
16. Berman ML, Keys H, Creasman W, et al: Survival and patterns of recurrence in cervical cancer metastatic to periaortic lymph nodes (a Gynecologic Oncology Group study). Gynecol Oncol 19:8-16, 1984 (Pubitemid 14027471)
17. Christensen A, Lange P, Nielsen E: Surgery and radiotherapy for invasive cancer of the cervix: Surgical treatment. Acta Obstet Gynecol Scand 43: 59-87, 1964
18. Wharton J, Jones H, Day T: Preirradiation celiotomy and extended field irradiation for invasive carcinoma of the cervix. Obstet Gynecol 49:333-338, 1977 (Pubitemid 8056922)
19. Hackett TE, Olt G, Sorosky JI, et al: Surgical predictors of para-aortic metastases in early-stage cervical carcinoma. Gynecol Oncol 59:15-19, 1995
20. Takeda N, Sakuragi N, Takeda M, et al: Multivariate analysis of histopathologic prognostic factors for invasive cervical cancer treated with radical hysterectomy and systematic retroperitoneal lymphadenectomy. Acta Obstet Gynecol Scand 81:1144-1151, 2002 (Pubitemid 35454363)
21. Morice P, Castaigne D, Pautier P, et al: Interest of pelvic and paraaortic lymphadenectomy in patients with stage IB and II cervical carcinoma. Gynecol Oncol 73:106-110, 1999 (Pubitemid 29177608)
22. Varia MA, Bundy BN, Deppe G, et al: Cervical carcinoma metastatic to para-aortic nodes: Extended field radiation therapy with concomitant 5-fluorouracil and cisplatin chemotherapy - A Gynecologic Oncology Group study. Int J Radiat Oncol Biol Phys 42:1015-1023, 1998 (Pubitemid 29004143)
23. Vigliotti AP, Wen BC, Hussey DH, et al: Extended field irradiation for carcinoma of the uterine cervix with positive periaortic nodes. Int J Radiat Oncol Biol Phys 23:501-509, 1992
24. Kim YS, Kim JH, Ahn SD, et al: High-dose extended-field irradiation and high-dose-rate brachytherapy with concurrent chemotherapy for cervical cancer with positive para-aortic lymph nodes. Int J Radiat Oncol Biol Phys 74:1522-1528, 2009
25. Zighelboim I, Taylor NP, Powell MA, et al: Outcomes in 24 selected patients with stage IVB cervical cancer and excellent performance status treated with radiotherapy and chemotherapy. Radiat Med 24:625-630, 2006 (Pubitemid 46074905)
26. Chao A, Ho KC, Wang CC, et al: Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. Gynecol Oncol 110:172-178, 2008
27. Yeh LS, Hung YC, Shen YY, et al: Detecting para-aortic lymph nodal metastasis by positron emission tomography of 18F-fluorodeoxyglucose in advanced cervical cancer with negative magnetic resonance imaging findings. Oncol Rep 9:1289-1292, 2002
28. Lin WC, Hung YC, Yeh LS, et al: Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. Gynecol Oncol 89:73-76, 2003 (Pubitemid 36403649)
29. Reinhardt MJ, Ehritt-Braun C, Vogelgesang D, et al: Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET. Radiology 218:776-782, 2001